- Canada’s
phased legalization of recreational-use cannabis highlights unfolding
opportunities in the cannabis space
- ChineseInvestors.com
is continuing to build its presence in the cannabis space while pressing
its advantage among Chinese-speaking consumers
- The
company is pursuing the possibility of a Nasdaq IPO for its cannabis
industry subsidiary later this year, and it’s also contemplating a move to
the NYSE or Nasdaq Small Cap Market
- Company
recently appointed Patrick Leung as its new CFO
Chinese language investor education service provider ChineseInvestors.com Inc. (OTCQB: CIIX) is flying high
as it explores Canada’s unfolding opportunities for the cannabis retail space
and the possibility of a Nasdaq IPO for wholly owned cannabis industry
subsidiary CBD Biotechnology Co. Ltd. later in the current fiscal year (http://ibn.fm/EqVoL), bolstering
its ambition for an uplisting to the New York Stock Exchange or Nasdaq Small
Cap Market within the next few years as the company reaches up to $10 million
in annual volume. In addition, the company recently appointed Patrick Leung as
its new CFO.
“I smell this tremendous, tremendous opportunity for (a)
Chinese cannabis company like us… I think of the tremendous opportunities here
because there’s not many competitors in the world like us, doing the cannabis
business for Chinese people,” ChineseInvestors.com CEO Warren Wang said in a
December interview (http://ibn.fm/r1S27).
Wang said that cannabis is one of the twin engines driving
CIIX’s flight plan, the other being bitcoin, although bitcoin has been
relegated to a backup position at the company’s investors’ request until its
market position revives, he indicated. Following up on the Chinese New Year in
February, ChineseInvestors.com is hoping to capitalize on cultural expectations
for wealth and well-being during the coming year. CBD Biotechnology recently
launched its first self-branded rice wine labeled ‘Hemp Wine’ (http://ibn.fm/pZMuE), and CIIX’s
second quarter report noted a revenue increase of more than 50 percent
year-over-year (http://ibn.fm/9zrSn).
While cannabis use in China is illegal, hemp-based CBD can
be legally added to cosmetics, thus opening a potential market of nearly two
billion people for the company. In the United States, the company is based in
San Gabriel, California, amid the nation’s largest cannabis market.
ChineseInvestors.com is celebrating the advancing tide of
cannabis legalization in the United States, including the Georgia House of
Representatives vote this month and the governor’s accompanying plan to
regulate the manufacture and sale of medical marijuana oil.
The company’s core focus is on offering investment education
to its Chinese-speaking audience through real-time market commentary, video
reports, podcasts and an online site, utilizing Chinese language character sets
(both traditional and simplified). CIIX also provides consulting services to
smaller private firms considering their public-listing options, as well as
advertising and public business-related support services.
The company is working with Medicine Man Denver to establish
a new intellectual property and experience-based corporate entity that will
provide licensing and consulting services within the cannabis sector.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates
relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
